Published: 18 April 2026
Author(s): Joao Modesto Dos Santos, Iñigo Les Bujanda, Paula Etayo-Urtasun, Julio Sánchez Álvarez, Mikel Izquierdo, Mikel L. Sáez De Asteasu, María Ruiz Castellano, Begoña Llorente Diez, Silvia Salinas Urra, Marta Pulido Fontes, Ramón Lecumberri
Section: Original Article
Venous thromboembolism (VTE) is a significant cause of preventable mortality in hospitalized patients. While risk assessment models such as Padua and IMPROVE-VTE scores have been validated in conventional hospitalization (CH), their applicability to hospital-at-home (HaH) remains uncertain.
